The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
- Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases Feb. 20, 2019 10:00 AM
- Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: Open-label extension of the NOR-SWITCH trial Feb. 15, 2019 10:00 AM
- Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort Feb. 15, 2019 10:00 AM